Why do conceptions of 'learning' vary so much in L2 learning research? Is there a conceptualisation of 'learning' to which members of different schools of SLA can subscribe? These questions and more are answered in this book by world-leading researchers in the field.

An exciting new collection by world-leading researchers in L2 learning addressing: Why do conceptions of 'learning' vary so much in L2 learning research? Is there a conceptualisation of 'learning' to which members of different schools of SLA can subscribe?

Due to a high incidence of anemia, critically ill patients are frequently transfused, with up to 40% of patients receiving a transfusion during their stay in the Intensive Care Unit. It has become increasingly clear that there is an association between transfusion and adverse outcomes, underlining the need for a careful assessment of the risks and benefits of a blood transfusion. In the last decade, there have been several large clinical trials that have studied red blood cell transfusion triggers in various ICU patient populations, allowing us to take a personalized approach to transfusion. Moreover, ICU patients often suffer from coagulopathy. Recent studies have addressed the effectiveness of fresh frozen plasma and platelets to prevent or treat bleeding. Aiming at a personalized therapy approach in transfusion practice, this book is the first to offer a comprehensive summary of transfusion triggers for red blood cells in specific ICU patient populations and specific conditions. In addition, it discusses evidence for triggers for plasma and platelets and outlines the most common adverse effects of transfusion in the ICU. Transfusion in the Intensive Care Unit is a practical handbook that can be used in everyday practice to guide transfusion and thus will serve as a valuable resource for physicians, fellows and residents working in Intensive Care, Anesthesiology and Cardiac Surgery.

Vor zehn Jahren hoerte ich zum ersten Mal von Outplacement. Dieser im deutschen Management noch ganzlich unbekannte Begriff wurde in der durchaus honorigen Absicht, den Fachwortschatz von weiteren Anglizismen freizuhalten, kurzzeitig gar zur "Fuhrungskrafteent- sorgung" verballhornt. Der Ex-und-hopp-und-Ab-auf-den-Mull-Bei- geschmack dieser Wortschoepfung tat ein ubriges, meine schlimmen Vermutungen uber eine neue, menschenverachtende Dimension im Umgang mit "ausgedienten" Mitarbeitern zu bekraftigen. Mein profes- sionelles Interesse an einer neuen Dienstleistung liess mir keine Ruhe, und ich untersuchte die Sache genauer. Dabei kam ich zu drei Einschat- zungen, die ich bis heute unverandert vertrete: 1. Outplacement per se ist nicht minder anruchig (ganz abgesehen von rechtlichen Problemen) als seine logische Umkehr, das Headhunting. Auftraggebern von Outplacementberatern sind durchaus nicht generell ehrenwerte Motive zu unterstellen. Nicht die Sorge um einen langjahri- gen Mitarbeiter oder wenigstens ein schlechtes Gewissen lassen den Berater auf den Plan treten, sondern haufig etwa nur die Hoffnung, die Angelegenheit besonders billig abwickeln zu koennen, obwohl das Outplacementangebot fallige Abfindungen nicht beruhrt. 2. Outplacement sollte nicht als grandiose personalpolitische Errun- genschaft gefeiert, sondern als Ultima ratio zur Schadensbegrenzung infolge personalpolitischen Missmanagements begriffen werden. Es sind nur Schutzbehauptungen, wenn Vorgesetzte vom allmahlichen Auseinanderdriften von Mitarbeiter- und Anforderungsprofil wie von einem geradezu naturwuchsigen Prozess sprechen. Eine wichtige Fuh- rungsaufgabe liegt eben darin, solche Entwicklungen fruhzeitig zu erkennen und Abhilfe zu schaffen. Die Handlungsalternativen sind zahlreich. Kommt es zum Outplacementfall, liegt dem immer ein meist lange zuruckliegendes arbeitgeberseitiges Versaumnis vor - ein Perso- nalmanagementfehler also.

When a patient is diagnosed with a gynecological malignancy, she and her doctors must make urgent, high-risk decisions about her course of treatment. In selecting an appropriate plan of care, physicians must weigh the patient's individual needs, the tumor's specific characteristics, and the treatment's potential side effects. Because there is no one-size-fits-all treatment solution, a plethora of clinical trials have been performed on ovarian cancer patients, but clinicians may struggle to keep up with this ever-growing body of research. Collecting and synthesizing research findings from a wide array of medical journal articles and book chapters, Clinical Trials in Ovarian Cancer provides physicians with an invaluable resource. Gynecologic oncologist Christine S. Walsh systematically outlines each of the seminal Phase III trials that have shaped the treatment of ovarian cancers, detailing the rationale for the trial, the patient population studied, treatment delivery methods, efficacy, toxicity, and trial conclusions. She provides a clear overview of established treatments, as well as still-controversial experimental approaches. The first book to organize this cutting-edge research into an easy-to-use reference, Clinical Trials in Ovarian Cancer should help medical personnel at all levels provide their patients with the highest standard of care.

This is a new release of the original 1924 edition.

This Is A New Release Of The Original 1920 Edition.

This scarce antiquarian book is a selection from Kessinger Publishing's Legacy Reprint Series. Due to its age, it may contain imperfections such as marks, notations, marginalia and flawed pages. Because we believe this work is culturally important, we have made it available as part of our commitment to protecting, preserving, and promoting the world's literature. Kessinger Publishing is the place to find hundreds of thousands of rare and hard-to-find books with something of interest for everyone!

Kessinger Publishing is the place to find hundreds of thousands of rare and hard-to-find books with something of interest for everyone!

This scarce antiquarian book is a selection from Kessinger Publishing's Legacy Reprint Series. Due to its age, it may contain imperfections such as marks, notations, marginalia and flawed pages. Because we believe this work is culturally important, we have made it available as part of our commitment to protecting, preserving, and promoting the world's literature. Kessinger Publishing is the place to find hundreds of thousands of rare and hard-to-find books with something of interest for everyone!

This scarce antiquarian book is a selection from Kessinger PublishingA AcentsAcentsa A-Acentsa Acentss Legacy Reprint Series. Due to its age, it may contain imperfections such as marks, notations, marginalia and flawed pages. Because we believe this work is culturally important, we have made it available as part of our commitment to protecting, preserving, and promoting the world's literature. Kessinger Publishing is the place to find hundreds of thousands of rare and hard-to-find books with something of intere